Supports gut barrier strength and digestive balance
People with obesity but not diabetes lost up to 24% of their initial body weight in 48 weeks
Pancreatitis Risk and Alcohol Interactions GLP-1 receptor agonists carry a class-labeling warning for acute pancreatitis based on FDA safety reviews
It is given as a onceweekly subcutaneous injection, typically in the abdomen, thigh, or upper arm
The resulting consensus provides an integrated synthesis of available evidence, incorporating data from RCTs, systematic reviews, meta-analyses, in vitro , and animal studies
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al